153 related articles for article (PubMed ID: 24906219)
1. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla.
Crocker CE; Bernier DC; Hanstock CC; Lakusta B; Purdon SE; Seres P; Tibbo PG
Schizophr Res; 2014 Aug; 157(1-3):231-7. PubMed ID: 24906219
[TBL] [Abstract][Full Text] [Related]
2. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
[TBL] [Abstract][Full Text] [Related]
3. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
4. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
5. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
6. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
8. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
9. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
[TBL] [Abstract][Full Text] [Related]
10. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.
Keshavan MS; Dick RM; Diwadkar VA; Montrose DM; Prasad KM; Stanley JA
Schizophr Res; 2009 Nov; 115(1):88-93. PubMed ID: 19748228
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
13. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
[TBL] [Abstract][Full Text] [Related]
14. Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Wang AM; Pradhan S; Coughlin JM; Trivedi A; DuBois SL; Crawford JL; Sedlak TW; Nucifora FC; Nestadt G; Nucifora LG; Schretlen DJ; Sawa A; Barker PB
JAMA Psychiatry; 2019 Mar; 76(3):314-323. PubMed ID: 30624573
[TBL] [Abstract][Full Text] [Related]
15. N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.
Zong X; Hu M; Li Z; Cao H; He Y; Liao Y; Zhou J; Sang D; Zhao H; Tang J; Lv L; Chen X
Sci Rep; 2015 Mar; 5():9109. PubMed ID: 25778460
[TBL] [Abstract][Full Text] [Related]
16. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
17. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
[TBL] [Abstract][Full Text] [Related]
18. Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Spitzberg K; Kersting A; Arolt V; Heindel W; Pfleiderer B
Schizophr Res; 2005 Mar; 73(2-3):153-7. PubMed ID: 15653258
[TBL] [Abstract][Full Text] [Related]
19. Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
Liemburg E; Sibeijn-Kuiper A; Bais L; Pijnenborg G; Knegtering H; van der Velde J; Opmeer E; de Vos A; Dlabac-De Lange J; Wunderink L; Aleman A
Sci Rep; 2016 Feb; 6():21873. PubMed ID: 26903078
[TBL] [Abstract][Full Text] [Related]
20. Reduced
Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
